Ophthalmic composition

  • US 10,201,534 B2
  • Filed: 02/13/2018
  • Issued: 02/12/2019
  • Est. Priority Date: 06/24/2014
  • Status: Active Grant
First Claim
Patent Images

1. An ophthalmic composition, comprising:

  • from about 0.001 wt % to about 0.05 wt % of a muscarinic antagonist;

    a buffer agent; and

    deuterated water;

    wherein the muscarinic antagonist is atropine or atropine sulfate.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×